EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 335 filers reported holding EXELIXIS INC in Q4 2019. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $345,767 | +13.5% | 15,825 | -0.7% | 0.22% | +21.2% |
| Q2 2023 | $304,587 | +0.7% | 15,939 | +2.2% | 0.18% | -4.7% |
| Q1 2023 | $302,590 | +24.6% | 15,589 | +2.9% | 0.19% | +13.5% |
| Q4 2022 | $242,922 | +1.6% | 15,145 | -0.7% | 0.17% | -1.2% |
| Q3 2022 | $239,000 | -22.1% | 15,253 | +3.3% | 0.17% | -21.1% |
| Q2 2022 | $307,000 | -14.0% | 14,760 | -6.3% | 0.22% | -3.1% |
| Q1 2022 | $357,000 | +35.2% | 15,759 | +9.3% | 0.22% | +44.2% |
| Q4 2021 | $264,000 | -21.2% | 14,418 | -9.0% | 0.16% | -28.1% |
| Q3 2021 | $335,000 | +20.1% | 15,838 | +3.4% | 0.22% | +14.8% |
| Q2 2021 | $279,000 | -21.0% | 15,321 | -2.1% | 0.19% | -27.6% |
| Q1 2021 | $353,000 | +15.0% | 15,642 | +2.4% | 0.26% | +6.5% |
| Q4 2020 | $307,000 | -21.1% | 15,275 | -4.0% | 0.24% | -31.6% |
| Q3 2020 | $389,000 | +8.7% | 15,905 | +5.5% | 0.36% | +1.1% |
| Q2 2020 | $358,000 | +34.7% | 15,079 | -2.3% | 0.35% | +11.0% |
| Q1 2020 | $265,748 | +5.0% | 15,433 | +7.4% | 0.32% | +30.7% |
| Q4 2019 | $253,000 | – | 14,366 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $199,507,000 | 56.91% |
| Sargent Investment Group, LLC | 1,032,560 | $18,193,000 | 3.40% |
| Bellevue Group AG | 3,930,700 | $69,259,000 | 1.10% |
| CAPITAL MANAGEMENT CORP /VA | 231,880 | $4,086,000 | 1.04% |
| Orbimed Advisors | 3,753,700 | $66,140,000 | 0.94% |
| TEALWOOD ASSET MANAGEMENT INC | 121,848 | $2,147,000 | 0.90% |
| FARALLON CAPITAL MANAGEMENT LLC | 7,500,000 | $132,150,000 | 0.89% |
| Chicago Capital, LLC | 806,113 | $14,204,000 | 0.87% |
| Penn Capital Management Company, LLC | 456,587 | $8,045,000 | 0.84% |
| AJO, LP | 7,636,882 | $134,561,000 | 0.80% |